Cystinuria drugs in development, 2024
The Cystinuria drugs in development market research report provides comprehensive information on the therapeutics under development for Cystinuria, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses key aspects of the companies and drugs in development for Cystinuria.
The report also covers the descriptive pharmacological action of the therapeutics and the latest news and press releases. Additionally, the report provides an overview of the key players involved in therapeutic development for Cystinuria and features dormant and discontinued products.
GlobalData tracks seven drugs in development for Cystinuria by seven companies/universities/institutes. The top development phase for Cystinuria is preclinical with four drugs in that stage. The Cystinuria pipeline has six drugs in development by companies and one by universities/ institutes. Some of the companies in the Cystinuria pipeline products market are: Advicenne, Bellvitge Biomedical Research Institute and Spyre Therapeutics.
The key targets in the Cystinuria pipeline products market include Calcium.
The key mechanisms of action in the Cystinuria pipeline product include Calcium Chelator with one drug in Phase III. The Cystinuria pipeline products include one routes of administration with the top ROA being Oral and four key molecule types in the Cystinuria pipeline products market including Small Molecule, and Biologic.